Screening for hepatocellular carcinoma in high-risk populations. Review uri icon

Overview

abstract

  • Screening for hepatocellular carcinoma (HCC) should be implemented in the high-risk population. High-risk population includes patients with cirrhosis of any etiology, patients with chronic hepatitis B virus with or without cirrhosis, and patients with chronic hepatitis C virus with cirrhosis. A randomized controlled trial of over 18,000 high-risk individuals demonstrated that biannual screening reduced HCC-related mortality by 37%. The screening test of choice is ultrasound imaging with an interval of 6 months.

publication date

  • November 23, 2015

Research

keywords

  • Carcinoma, Hepatocellular
  • Early Detection of Cancer
  • Liver Neoplasms

Identity

Scopus Document Identifier

  • 84969326669

Digital Object Identifier (DOI)

  • 10.1016/j.clinimag.2015.11.010

PubMed ID

  • 26898986

Additional Document Info

volume

  • 40

issue

  • 2